Findings on Melanoma Reported by Researchers at Oklahoma State University Center for Health Sciences (Assessing patient risk, benefit, and outcomes in drug development: a decade of vemurafenib clinical trials)

Media coverage

• Title	Findings on Melanoma Reported by Researchers at Oklahoma State University Center for Health Sciences (Assessing patient risk, benefit, and outcomes in drug development: a decade of vemurafenib clinical trials)
  Media name/outlet	CDC & FDA Daily
  Country/Territory	United States
  Date	24/12/25
  Persons	Matt Vassar, Ryan Ottwell, Griffin Hughes, Kelsey Snider